JPMorgan Chase & Co. Has $2.25 Million Stake in Transcat, Inc. $TRNS

JPMorgan Chase & Co. raised its stake in Transcat, Inc. (NASDAQ:TRNSFree Report) by 259.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 30,719 shares of the scientific and technical instruments company’s stock after buying an additional 22,164 shares during the quarter. JPMorgan Chase & Co.’s holdings in Transcat were worth $2,249,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Transcat by 6.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock worth $407,000 after acquiring an additional 325 shares in the last quarter. Linden Thomas Advisory Services LLC increased its holdings in shares of Transcat by 4.4% in the third quarter. Linden Thomas Advisory Services LLC now owns 10,840 shares of the scientific and technical instruments company’s stock worth $793,000 after acquiring an additional 453 shares in the last quarter. PNC Financial Services Group Inc. increased its holdings in shares of Transcat by 42.7% in the third quarter. PNC Financial Services Group Inc. now owns 1,530 shares of the scientific and technical instruments company’s stock worth $112,000 after acquiring an additional 458 shares in the last quarter. Verition Fund Management LLC increased its holdings in shares of Transcat by 6.4% in the third quarter. Verition Fund Management LLC now owns 8,982 shares of the scientific and technical instruments company’s stock worth $657,000 after acquiring an additional 539 shares in the last quarter. Finally, Legal & General Group Plc increased its holdings in shares of Transcat by 6.1% in the second quarter. Legal & General Group Plc now owns 9,551 shares of the scientific and technical instruments company’s stock worth $821,000 after acquiring an additional 548 shares in the last quarter. 98.34% of the stock is currently owned by institutional investors.

Transcat Stock Down 0.9%

NASDAQ:TRNS opened at $75.48 on Tuesday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.85 and a current ratio of 2.21. The company has a market cap of $704.23 million, a PE ratio of 88.80 and a beta of 0.71. Transcat, Inc. has a 52-week low of $50.23 and a 52-week high of $97.08. The stock has a 50-day simple moving average of $73.34 and a 200 day simple moving average of $66.79.

Transcat (NASDAQ:TRNSGet Free Report) last posted its quarterly earnings data on Tuesday, February 3rd. The scientific and technical instruments company reported $0.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.04). The firm had revenue of $83.86 million for the quarter, compared to the consensus estimate of $80.99 million. Transcat had a return on equity of 6.15% and a net margin of 2.47%. On average, sell-side analysts expect that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Analyst Ratings Changes

TRNS has been the subject of several recent analyst reports. Weiss Ratings restated a “sell (d+)” rating on shares of Transcat in a report on Monday, December 29th. Zacks Research upgraded Transcat from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 4th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Transcat has a consensus rating of “Moderate Buy” and an average target price of $105.33.

Get Our Latest Stock Analysis on TRNS

Transcat Company Profile

(Free Report)

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.

Recommended Stories

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNSFree Report).

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.